Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF – Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 25,129 shares, a drop of 44.9% from the August 15th total of 45,628 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.
Shin Nippon Biomedical Laboratories Stock Performance
OTCMKTS SBLOF opened at $7.00 on Tuesday. Shin Nippon Biomedical Laboratories has a one year low of $7.00 and a one year high of $9.16. The business’s fifty day moving average is $7.00 and its 200-day moving average is $8.23.
Shin Nippon Biomedical Laboratories Company Profile
Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.
The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.
Further Reading
- Five stocks we like better than Shin Nippon Biomedical Laboratories
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Shin Nippon Biomedical Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shin Nippon Biomedical Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
